C-suite executives and board members in the antibiotics industry have become increasingly aware of ESG and how it affects their strategy, companies’ future performance and their value. An ominous rise of antibiotic-resistant bacteria has sent shockwaves among manufacturers, compelling them to integrate ESG into their business operations. The Lancet noted in its 2021 study that...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian